Introduction {#Sec1}
============

*N*-ethyl-*N*-nitrosourea (ENU) mutagenesis in the mouse has played an important role in identifying genes involved with a number of disease systems (Justice et al. [@CR13]). By carrying out wide-ranging phenotypic screens on mice carrying dominant and recessive ENU mutations, the functional effects of these mutations can be investigated (Brown et al. [@CR2]; Hrabe de Angelis et al. [@CR10]). The large-scale ENU mutagenesis program at MRC Harwell originally focused on dominant ENU mutations (Nolan et al. [@CR20]), but it has expanded to screen mice for both dominantly and recessively inherited ENU mutations. Both phenotype-driven and gene-driven screens have helped identify many novel genes and alleles of existing genes involved with hereditary deafness and hearing loss (Brown et al. [@CR3]).

Caspases are a group of cysteine proteases that play an essential role in programmed cell death (PCD) caused by apoptosis (Nicholson [@CR19]). Caspases ([c]{.ul}ysteinyl [asp]{.ul}artate-specific prote[ases]{.ul}) cleave substrates directly after an aspartic acid residue (Cohen [@CR4]). Caspases share several structural similarities, all containing an N-terminal pro-domain followed by a large subunit approximately 20 kDa in size (p20) and a small subunit of roughly 10 kDa (p10). They are synthesised in a dormant form and require proteolysis by cleavage at specific aspartate residues to become mature (Earnshaw et al. [@CR6]). There are at least 14 mammalian caspases, which are classified according to their function and structure. Group I, comprising Caspases 1, 4, 5, 11, 12, 13, and 14, are known as the inflammatory caspases. Groups II and III are known as the apoptotic caspases. Group II caspases are the upstream initiator caspases that mediate the apoptotic response and consist of Caspases 2, 8, 9, and 10 and are activated by apoptotic signalling pathways. Downstream are the executioner caspases, Group III, comprising Caspases 3, 6, and 7, that are activated by the initiator caspases and represent the subclass of the caspase family that perform the proteolytic cleavage of apoptotic target proteins (Lavrik et al. [@CR16]). Caspase 3 has been shown to be one of the main apoptotic executioner caspases and is either partially responsible or essential for the cleavage of many specific proteins during apoptosis (Cohen [@CR4]).

We have identified a new deafness mutant *melody* from the ENU recessive screen at MRC Harwell. Homozygote *melody* mice display severe sensorineural hearing loss and hair cell and stereocilia bundle defects, similar to that reported for *Casp3* knockout mice (Morishita et al. [@CR17]; Takahashi et al. [@CR21]). We have characterised in detail the effects of the mutation on the spiral ganglion and have revealed a gradient of severity across the cochlear turns as well as evidence of dominant effects in the heterozygote. We show here that the *melody* mutant carries a point mutation in Caspase 3 that changes the key catalytic cysteine residue to serine. This exact substitution is often employed *in vitro* for the study of Caspase-3 activity (Bose and Clark [@CR1]; Feeney and Clark [@CR7]; Gu et al. [@CR8]; Kang et al. [@CR14]; Van Criekinge et al. [@CR22]) and as such *melody* provides a complementary in vivo model.

Materials and methods {#Sec2}
=====================

Mice {#Sec3}
----

All animals were housed and maintained in the Mary Lyon Centre at the MRC Harwell, under specific pathogen-free (SPF) conditions in individually ventilated cages, with environmental conditions as outlined in the Home Office Code of Practice. Animal procedures were carried out in line with Home Office regulations, and mice were euthanized by Home Office Schedule 1 methods.

The *melody* mutant line was derived from a recessive pedigree from the ENU mutagenesis screen at the MRC MGU Harwell. ENU-treated G0 C57BL/6 male mice were mated to C3H female mice to produce G1 progeny. Female G1 mice were backcrossed to the ENU-treated G0 founder male to produce G3 mice which were screened for phenotypes caused by recessive mutations. The *melody* line was maintained on a C3H genetic background by outcrossing and intercrossing successive generations. *Caspase-3* null mice (B6.129S1-*Casp3*^*tm1Flv*^/J) were imported from The Jackson Laboratory (Bar Harbor, ME, USA) and rederived by *in vitro* fertilisation by the FESA core in the Mary Lyon Centre to maintain SPF status. The null mice were continually backcrossed to C3H.

Clickbox {#Sec4}
--------

Mice were placed in the palm of the hand and tested with a clickbox (Institute of Hearing Research, Nottingham, UK), which produces a brief audio stimulus of \~ 20-kHz tone at 90 dB when held 30 cm away from the subject. Mice with unaffected hearing display the "preyer" response, a backwards flick of the ear pinnae. In most cases the preyer reflex is followed by a startled response that can range from a contracting of the neck muscles to a rapid jump backwards. A lack of either of the responses was recorded as no response to the clickbox (Hardisty-Hughes et al. [@CR9]).

Auditory-evoked brainstem response analysis (ABR) (see Hardisty-Hughes et al. [@CR9]) {#Sec5}
-------------------------------------------------------------------------------------

Mice were anaesthetised with ketamine (Ketaset^TM^) and medetomidine (Domitor^TM^) (0.5 ml Domitor at 100 mg/ml with 4.12 ml water and 0.38 ml Ketaset at 1 mg/ml; administered at a rate of 0.1 ml/10 g body weight). Animals were placed on a heated mat in an audiometric chamber (IAC 401-A-SE). Electrodes (Grass Telefactor F-E2-12) were placed subdermally over the vertex (active), right mastoid (reference), and left mastoid (ground). ABR responses were collected, amplified and averaged using TDT system III hardware and software (Tucker Davis Technology, Alachua, FL, USA). Click stimuli consisted of a 0.1-ms broadband click of alternating polarity. Tone-burst stimuli totalled 7-ms duration, including 1-ms rise/fall time; frequencies used were 8, 12, 20, and 26 kHz.

Genetic mapping {#Sec6}
---------------

Extraction of DNA from mouse ear biopsies and PCR were performed using standard protocols. Single nucleotide polymorphism (SNP) markers, polymorphic between the parent C57BL/6 and C3H strains, were selected using the Mouse Phenome Database (MPD) (<http://phenome.jax.org/pub-cgi/phenome/mpdcgi?rtn=snps/door>). An initial genome scan using DNA from affected G3 mice was performed using a panel of SNP markers by pyrosequencing on a PSQ HS 96A pyrosequencer (Biotage AB). After linkage was found, fine mapping was performed by selecting further SNP markers to narrow the nonrecombinant region.

Candidate gene selection and mutation detection {#Sec7}
-----------------------------------------------

A list of genes that map to the nonrecombinant region identified in the genome scan was obtained using the Ensembl database (<http://www.ensembl.org/Mus_musculus/Info/Index>). Candidates were selected by searching the Mouse Genome Informatics (MGI) database (<http://www.informatics.jax.org/searches/allele_form.shtml>) for genes known to be connected with hearing loss. Primers were designed around the exons of candidate genes, and DNA from *melody* homozygote, heterozygote, and both parental strains was PCR amplified and sent for genetic sequencing (Geneservice, Oxford, UK). For mutation detection the resulting sequence was analysed using DNAbaser v2 (Cubic Design) software.

Genotyping {#Sec8}
----------

The *melody* (*Casp3*^*mldy*^) mutation introduced a *Sma*I restriction site. This enabled a genotyping assay to be performed by PCR amplification of exon 6 of *Casp3* with the primers 5′-CTT CCT AGT TCT CAG ACC ACA CTT-3′ and 5′-CAT TTT CTC ACC AGG TGC TGT-3′, yielding a product of 225 bp. Upon digestion with *Sma*I, only the 225-bp band is visible in +/+ genomic DNA, two bands of 100 and 125 bp can be seen in *Casp3*^*mldy*^*/Casp3*^*mldy*^, and all three bands are present in *Casp3*^*mldy*^*/+*. *Casp3*^*tm1Flv*^ mice were genotyped by PCR amplification in accordance with the protocol outlined on The Jackson Laboratory website (<http://jaxmice.jax.org/protocolsdb/f?p=116:2:954450999895056::NO:2:P2_MASTER_PROTOCOL_ID,P2_JRS_CODE:3892,006233>).

Histological analysis (see Hardisty-Hughes et al. [@CR9]) {#Sec9}
---------------------------------------------------------

Animals were euthanized by cervical dislocation. The heads were removed, skinned, and bisected down the midline before fixation by submersion in 10% neutral buffered formaldehyde. Fixed specimens were decalcified and embedded in paraffin. Five-micrometre-thick sagittal sections were obtained and stained with H&E according to standard protocols. For spiral ganglion neuron density measurements, slides were digitally scanned using a Hamamatsu NanoZoomer slide scanner and the area containing the spiral ganglion neurons (Rosenthal's canal) was calculated using NDP serve software. Spiral ganglion neurons were counted (no distinction was made between Type I and II cells) and normalised to the calculated area. A Levene test of homogeneity of variances was performed and subsequent statistical analysis was performed using an ANOVA. As a result of the Levene test, Tamhane post hoc analysis was used for the mid and basal turns, and Tukey HSD post hoc analysis was used for the apical turn in SPSS software (SPSS, Inc., Chicago, IL).

Scanning electron microscopy (see Hardisty-Hughes et al. [@CR9]) {#Sec10}
----------------------------------------------------------------

Animals were euthanized and heads skinned and bisected as previously described. Inner ears were dissected and fixed in 2.5% glutaraldehyde in a 0.1 potassium phosphate buffer solution for 3--4 h before decalcification by submersion in 4.3% EDTA for 48 h. Fine dissection was performed to remove the cochlear shell and stria-vascularis before osmium tetroxide--thiocarbohydrazide (OTOTO) processing (adapted from Hunter-Duvar [@CR11]) was utilised to preserve stereocilia structure. Specimens were then dehydrated by submersion in ethanol solutions of increasing strength and stored in acetone until critical-point drying was performed using Emitech K850 (EM Technologies Ltd, Ashford, Kent, UK). Sputter coating was achieved using a Polaron instruments Inc. E5100. The specimens were examined with a Hitachi S-530 scanning electron microscope.

Protein extraction and fractionation {#Sec11}
------------------------------------

Protein was extracted using CelLytic NuCLEAR Extraction kit (Sigma-Aldrich, NXTRACT-1KT 078K4112). E17.5 heads were lysed in 1× lysis buffer containing protease inhibitors using a glass homogenizer. Nuclei were pelleted by centrifugation, and the cytoplasmic fraction contained in the supernatant was separated. Ten micrograms of each cytoplasmic protein sample were run on a 12% Bis-Tris minigel (Invitrogen, NP0341BOX); the nuclear fraction was discarded.

Western blotting {#Sec12}
----------------

Protein was transferred onto a nitrocellulose membrane (Invitrogen LC2000) and blocked in TBS containing 5% dry skimmed milk and 0.1% Tween 20. The membrane was incubated with a Caspase-3 antibody (Cell Signalling \#9662) at 1:500 dilution in blocking solution overnight at 4°C. Secondary anti-rabbit HRP-conjugated antibody (Sigma Aldrich A4914) was used at 1:10,000 dilution in blocking solution for 1 h at room temperature. Membranes were washed four times after both primary and secondary antibody incubations in TBS + 0.1% Tween 20. Enhanced chemiluminescence (GE Healthcare, RPN2109) was used as the detection system. An α-tubulin antibody (Abcam, ab15246) at 1:500 dilution was used as described above as a loading control.

Results {#Sec13}
=======

Identification of the *melody* mutant {#Sec14}
-------------------------------------

The *melody* (*mldy*) mutant was identified from a recessive ENU sensory screen undertaken at the MRC Mammalian Genetics Unit, Harwell (see "[Materials and methods](#Sec2){ref-type="sec"}"). The founder G3 mice carrying the *melody* mutation appeared slightly smaller than littermates and had no response to a clickbox. Some mutants were observed to have cranial protuberances (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1**a** An example of an abnormal growth on the head of a *mldy/mldy* mouse, probably due to hyperplasia of various cells in the brain. **b, c** A comparison of +/+ (**b**) and *mldy/mldy* (**c**) mice with abnormal protrusions from the brain at E17.5. This phenotype was seen in 50% of *mldy/mldy* embryos examined and probably results in embryonic lethality in most cases, leading to the lower than expected numbers of *mldy/mldy* born (11.4%)

Genetic mapping and candidate gene selection {#Sec15}
--------------------------------------------

An initial genome scan using a total of 13 progeny \[both G3 progeny (*n* = 2) and G5 progeny (*n* = 11)\] showed linkage to chromosome 8. Subsequent fine mapping of 57 affected mice (from subsequent generations to G11) with SNP markers narrowed the mutant locus to approximately 6 Mb between the markers rs32804682 and rs37373014, a region containing approximately 60 genes. In this region there were a number of candidate genes that had known mutations demonstrating a hearing loss phenotype. Caspase 3 represented a good candidate as mice lacking Caspase 3 were reported to have similar phenotypic traits to those observed in *mldy/mldy* mice (Kuida et al. [@CR15]; Morishita et al. [@CR17]; Takahashi et al. [@CR21]).

DNA from *mldy/mldy* and *mldy/+* mice was PCR amplified using primers for each of the six exons of *Casp3* and the sequence examined for mutations. The sequence contained a G-to-C transversion of nucleotide 489 of *Casp3* located in exon 6 (Fig. [2](#Fig2){ref-type="fig"}a), causing a nonconservative cysteine-to-serine change at amino acid 163. The residue changed by the *melody* mutation is the catalytic cysteine of murine Caspase 3 and is highly conserved through evolution (Fig. [2](#Fig2){ref-type="fig"}b). Not only is this catalytic cysteine conserved in Caspase 3, it is central in the pentapeptide active site motif QACXG (X being R, G, or Q) conserved in all caspases (Cohen [@CR4]) (Fig. [2](#Fig2){ref-type="fig"}c).Fig. 2A Caspase-3 mutation in the *melody* mutant. **a** Sequence at and around nucleotide 489 (highlighted by *red ovals*) of the exonic sequence of *Casp3*. The sequence shows cytosine at nucleotide 489 in the C57BL/6 J and C3H parental strains and guanine at the same point in the *Casp3*^*mldy*^*/Casp3*^*mldy*^ sequence. The *Casp3*^*mldy*^*/+* sequence shows both cytosine and guanine. Note that the reverse complement sequence is shown; therefore, the *melody* mutation is G489C. **b** Evolutionary conservation of the catalytic cysteine residue of Caspase 3 altered to serine in the *melody* mutant (*black box*). **c** Conservation of the QACXG pentapeptide active site motif (*black box*), which is present in all caspases. An alignment of peptide sequences from all the murine caspases is shown; the residue number refers to Caspase 1

Complementation testing and phenotyping {#Sec16}
---------------------------------------

We undertook to confirm our identification of the *melody* (*Casp3*^*mldy*^) mutation by complementation testing with the Caspase-3-null mutant *Casp3*^*tm1Flv*^. Moreover, in parallel we carried out an extensive and detailed auditory and phenotypic analysis of both melody and null mutations as well as compound genotypes.

Clickbox phenotyping {#Sec17}
--------------------

We generated 537 intercross offspring from *Casp3*^*mldy*^*/+* matings and assessed them for auditory function with a clickbox at four weeks of age. Of these, 61 mice (11.4%) were deaf by clickbox as they did not exhibit the preyer reflex or any form of startle response. All of these mice were genotyped as *Casp3*^*mldy*^*/Casp3*^*mldy*^. In contrast, all *Casp3*^*mldy*^*/+* and +/+ mice showed a preyer reflex in response to the clickbox.

We generated 68 offspring from matings of *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice to *Casp3*^*tm1Flv*^*/+* mutants. From these progeny, 23 (33.8%), all of which genotyped as *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^, showed no response to the clickbox at four weeks of age, indicating noncomplementation and confirming that a mutation in Caspase 3 is the cause of deafness in *melody* mutants. We also generated 159 progeny from *Casp3*^*tm1Flv*^/+ intercross matings. From these, 18 (11.3%) were genotyped as *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^, none of which showed a response to the clickbox at four weeks of age. In contrast, all *Casp3*^*tm1Flv*^/+ *and +/+* mice showed the preyer response to the clickbox.

Embryonic phenotyping {#Sec18}
---------------------

The number of *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice born is significantly lower than the 25% that would be expected according to Mendelian inheritance from a recessive mating scheme (χ^2^*P* = 3 × 10^−13^). To investigate this further, we opened up females from two intercrosses, one *Casp3*^*mldy*^*/+* × *Casp3*^*mldy*^*/+* and one *Casp3*^*mldy*^*/Casp3*^*mldy*^ × *Casp3*^*mldy*^*/+* , and harvested 19 embryos at 17.5 dpc. Of these, six were genotyped as *Casp3*^*mldy*^*/Casp3*^*mldy*^ and 50% of these displayed severe blebs on their head (Fig. [1](#Fig1){ref-type="fig"}c), possibly due to hyperplasia of the brain, which may have led to prenatal losses.

ABR analysis {#Sec19}
------------

We analysed both *melody* and *Casp3*-null mice by ABR to establish in detail the nature of the hearing impairment. Twelve-week-old *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice (*n* = 5) were subjected to tone-burst ABR assessment. None of the *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice showed an ABR response at any of the test frequencies, 8, 12, 20, and 26 kHz, at the maximum level tested, 90 dB SPL (for graphical representation, this was recorded as a threshold of 100 dB SPL). In contrast, *+/+* mice all showed threshold levels typical for wild-type mice of the same age (Fig. [3](#Fig3){ref-type="fig"}a, b). Because no ABR response was seen at any frequencies using tone bursts, it was deemed that further ABR assessment using a click stimulus would be sufficient to characterise the deafness phenotype.Fig. 3ABR data from *melody* mutant mice. **a** Representative traces from 12-week-old +/+ and *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice in response to 12-kHz tone-burst stimuli at decreasing stimuli levels. In the wild-type mice, the five main ABR peaks can be seen in response to the stimulus at levels down to 30 dB SPL. In the *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice, no peaks are observed at any of the stimulus levels. **b** Audiogram showing average ABR threshold levels for 12-week-old +/+ and *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice (*n* = 5). The *error bars* denote the standard error of the mean. *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice showed no response to the highest stimulus level (90 dB SPL) at any of the test frequencies (8, 12, 20, and 26 kHz). For graphical representation, the *Casp3*^*mldy*^*/Casp3*^*mldy*^ thresholds are plotted as 100 dB SPL. **c** Average ABR thresholds in response to a click stimulus of *+/+* (*n* = 10, with three aged 4 weeks and seven aged 8 weeks)*, Casp3*^*mldy*^*/+* (*n* = 20 with four aged 4 weeks and 16 aged 8 weeks), *Casp3*^*tm1Flv*^/+ (*n* = 12 with all aged 8 weeks), *Casp3*^*mldy*^*/Casp3*^*mldy*^ (*n* = 4 with one aged 4 weeks and three aged 8 weeks), *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ (*n* = 4 with all aged 8 weeks), and *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ (*n* = 11 with all aged 8 weeks). All *+/+*, *Casp3*^*mldy*^*/+* , and *Casp3*^*tm1Flv*^/+ mice had ABR thresholds between 15 and 30 dB SPL. No response to the highest stimulus level (90 dB SPL) was seen in any of the *Casp3*^*mldy*^*/Casp3*^*mldy*^, *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^, or *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^. For graphical representation, thresholds are plotted as 100 dB SPL

To confirm the lack of a heterozygous deafness phenotype, an outcross litter arising from a *Casp3*^*mldy*^*/Casp3*^*mldy*^ to C3H mating was tested at 14 weeks of age. These mice (all *Casp3*^*mldy*^*/+*) had click ABR thresholds between 20 and 25 dB SPL (data not shown). An additional 23 animals between 4 and 8 weeks of age and arising from *melody* intercross matings were tested by click ABR. There were four *Casp3*^*mldy*^/*Casp3*^*mldy*^ mice in this group, all of which failed to show response to the click ABR stimulus at the maximum level tested (90 dB SPL). All +*/*+ and *Casp3*^*mldy*^*/+* mice had click ABR thresholds ranging from 15 to 30 dB SPL (Fig. [3](#Fig3){ref-type="fig"}c).

A total of 27 progeny from *Casp3*^*tm1Flv*^/+ intercross matings underwent click ABR testing at 8 weeks of age (Fig. [3](#Fig3){ref-type="fig"}c). From these, four genotyped as *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ and showed no response to the click stimulus at 90 dB SPL. All *Casp3*^*tm1Flv*^/+ and *+*/*+* mice had ABR thresholds between 20 and 25 dB SPL. As expected, click ABR performed on 8-week-old offspring from the complementation matings demonstrated that *Casp3*^*mldy*^/*Casp3*^*tm1Flv*^ mice (*n* = 11) failed to elicit any response to the 90 dB SPL click stimulus. A summary of the click ABR data can be seen in Fig. [3](#Fig3){ref-type="fig"}c.

We also carried out ABRs to determine if there was evidence of hearing loss at earlier time points and analysed a small number of mice for each genotype at two weeks. These included two *Casp3*^*mldy*^/*Casp3*^*mldy*^ and two *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ mice, all of which failed to show a response to a 90-dB-SPL click ABR stimulus. Four *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ mice were also tested: three failed to show a response to the highest-level click stimulus and one had a click ABR threshold of 75 dB SPL. All +/+ (*n* = 7) and heterozygote mice \[*Casp3*^*tm1Flv*^/+ (*n* = 11), *Casp3*^*mldy*^*/+* (*n* = 4)\] had ABR thresholds between 20 and 35 dB SPL, with the exception of one *Casp3*^*tm1Flv*^*/+* mouse which had a threshold of 50 dB SPL. This mouse was very small compared to littermates and it is possible this elevated threshold was due to either ill health or difficulties with electrode placement because of the very small size of the animal. These data show that by two weeks of age, shortly after the onset of hearing in mice, *Casp3*^*mldy*^*/Casp3*^*mldy*^, *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^, and *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ already display severe hearing loss.

Western blot analysis {#Sec20}
---------------------

We analysed protein levels in both *melody* and *Casp3*-null mutants as well as in compound genotypes. Caspase 3 is located mainly in the cytoplasm in its uncleaved form. Therefore, we proceeded to fractionate the total protein into cytoplasmic and nuclear fractions. Cytoplasmic protein extracted from E17.5 heads from all genotypic variants was probed with a Caspase-3 antibody (Fig. [4](#Fig4){ref-type="fig"}). There was no significant difference in Caspase-3 levels between *Casp3*^*mldy*^*/+* , C3H, and +/+ mice (C3H/C57BL/6 J). Caspase-3 levels were significantly lower in *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice compared to controls, and although not significantly different than in controls, the levels in *Casp3*^*mldy*^*/+* mice were intermediate between wild-type and *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice. *Casp3*^*tm1Flv*^/+ levels were around half that seen in wild-type mice and levels in *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ mice were further reduced. In addition, protein levels in *Casp3*^*tm1Flv*^/+ and *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ were significantly lower when compared with that in *Casp3*^*mldy*^*/+* (*P* ≤ 0.05). As expected, the level of Caspase 3 in the *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ was significantly lower than in *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice (*P* ≤ 0.05). *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ animals were confirmed as null by the lack of any observable protein.Fig. 4Western blot analysis of cytoplasmic protein from E17.5 heads of *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^, *Casp3*^*mldy*^/*Casp3*^*tm1Flv*^, *Casp3*^*tm1Flv*^/*+*, *+/+*, C3H, *Casp3*^*mldy*^*/Casp3*^*mldy*^, and *Casp3*^*mldy*^*/+* mice (*n* = 3). **a** Average protein expression levels from each of the genotypes with the standard error of the mean. Protein levels are normalised with α-tubulin as a loading control. An ANOVA was performed using Tukey HSD post hoc analysis. Significant differences in protein levels are shown: \* reduced compared to C3H or +/+ (*P* ≤ 0.05); †, reduced compared to *Casp3*^*mldy*^*/+* (*p* ≤ 0.05); §, reduced compared to *Casp3*^*mldy*^*/Casp3*^*mldy*^ (*p* ≤ 0.05); and ¥, reduced compared to *Casp3*^*tm1Flv*^/*+* (*p* ≤ 0.05). **b** An example Western blot probed with the Caspase-3 antibody and the α-tubulin loading control

Scanning electron microscopy {#Sec21}
----------------------------

Scanning electron micrographs (SEM) were obtained from *Casp3*^*mldy*^*/Casp3*^*mldy*^, *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^, *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^, *Casp3*^*tm1Flv*^/+ , *Casp3*^*mldy*^*/+* , and +/+ mice between 2 and 3 months old. The images show that *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice display severe abnormalities of both inner-hair-cell (IHC), and outer-hair-cell (OHC) stereocilia bundles (Fig. [5](#Fig5){ref-type="fig"}). The three organised rows of OHCs seen in the organ of Corti of *+/+* mice are not observed in *Casp3*^*mldy*^*/Casp3*^*mldy*^ animals (Fig. [5](#Fig5){ref-type="fig"}ai--di). Extensive abnormalities of OHCs in the organ of Corti are observed in *Casp3*^*mldy*^*/Casp3*^*mldy*^, *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^, and *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ when compared to wild--type mice, including stereocilia fusion and hair cell loss. The severity of hair cell degeneration varies along the cochlea, although there is no observable pattern between specimens. Some small areas of the organ of Corti are unaffected and show what appears to be normal OHC stereocilia morphology, and others totally lack OHC stereocilia. In addition to the widespread degeneration, some of the remaining OHC stereocilia appear to be fused at the tips, and separate bundles also appear connected (Fig. [5](#Fig5){ref-type="fig"}aiii--diii). Similar stereocilia abnormalities, including the connecting material between OHC bundles, were previously reported in the B6.129S1-*Casp3*^*tm1Flv*^/J -ull mice (Takahashi et al. [@CR21]); however, we cannot rule out that this phenotype is due to an artefact. Extensive abnormalities are also seen for IHCs. Most of the IHC stereocilia have also fused together and are larger than normal size, although IHC degeneration is not as severe or widespread as that of the OHCs (Fig. [5](#Fig5){ref-type="fig"}aii--dii). These hair cell abnormalities are not seen in the *Casp3*^*mldy*^*/+* or *Casp3*^*tm1Flv*^/+ mice (data not shown).Fig. 5Scanning electron micrographs showing abnormal hair cell morphology in the cochlea of *Casp3*^*mldy*^*/Casp3*^*mldy*^ (*n* = 3), *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ (*n* = 2), *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ (*n* = 2), and +/+ mice (*n* = 2) aged 2--3 months. Panel (*a i*) shows a wild-type organ of Corti, and three well-organised rows of outer hair cells (OHC) and one row of inner hair cells (IHC) are visible. *Casp3*^*mldy*^*/Casp3*^*mldy*^ (*bi*), *Casp3*^*mldy*^*/ Casp3*^*tm1Flv*^ (*c i*), and *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ (*d i*) display OHC degeneration and abnormalities of the stereocilia bundles of IHCs and OHCs. Panels (*a ii*)--(*d ii*) show higher-magnification images of the IHCs, and panels (*a iii*)--(*d iii*) show higher-magnification images of the OHCs. *Casp3*^*mldy*^*/+* (*n* = 3) and *Casp3*^*tm1Flv*^/+ (*n* = 2) mice were also analysed (data not shown) but showed no differences to wild-type (see "[Results](#Sec13){ref-type="sec"}")

Histology {#Sec22}
---------

Histological examination of sagittal sections from the cochlea of 8-week-old mice show reduced numbers of spiral ganglion (SG) neurons in *Casp3*^*mldy*^*/Casp3*^*mldy*^, *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^, and *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ mice (Figs. [6](#Fig6){ref-type="fig"} and [7](#Fig7){ref-type="fig"}a). We have determined SG neuron density in apical, mid, and basal turns of +/+, *Casp3*^*mldy*^*/+* , *Casp3*^*mldy*^*/Casp3*^*mldy*^, *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^, and *Casp3*^*mldy*^*/ Casp3*^*tm1Flv*^ mice (Fig. [7](#Fig7){ref-type="fig"}a, b). There were no significant differences in SG neuron density between *+/+* and *Casp3*^*tm1Flv*^/+ mice in any of the turns of the cochlea. *Casp3*^*mldy*^*/+* appeared to show reduced SG density compared with +/+ and *Casp3*^*tm1Flv*^/+ mice in all turns of the cochlea, with significant differences seen when compared to *Casp3*^*tm1Flv*^/+ in the apical and mid turns (*P* \< 0.05). *Casp3*^*mldy*^*/Casp3*^*mldy*^ and *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ mice showed significantly reduced SG neuron density in all cochlear turns when compared to +/+ and *Casp3*^*tm1Flv*^/+ (*P* \< 0.05). *Casp3*^*mldy*^*/Casp3*^*mldy*^ SG density was lower than that of *Casp3*^*mldy*^*/+* in all turns but was only statistically significant in the basal turn (*P* \< 0.05). Interestingly, the *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ mice showed a reduction in density in the mid and basal turns compared to +/+ (*P* \< 0.05), but not in the apical turn where, in fact, SG density was significantly higher than in *Casp3*^*mldy*^*/+* and *Casp3*^*mldy*^*/Casp3*^*mldy*^ (*P* \< 0.05). Finally, the SG neuron density in *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ mice was lower than in *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ and this was found to be significant in the apical turns, although it is here that *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ mice have a higher SG neuron density.Fig. 6Histological analysis of the spiral ganglion in the *melody* mutant. H&E stained sections from the apical, mid, and basal turns of the cochlea from 2-month-old mice of each genotype are displayed. The degeneration in the apical turns is not as severe as the mid or basal turns. *Scale bars* = 100 μmFig. 7Analysis of spiral ganglion neuron densities between genotypes and between cochlear turns. **a** Spiral ganglion neuron densities for each genotype in the apical, mid, and basal turns of the cochlea are presented. The number of spiral ganglion neurons were counted and normalised to the area of Rosenthal's canal in each section to provide the spiral ganglion neuron density in mm^2^. *Error bars* denote standard error of the mean. Six sections from each genotype were analysed. **b** Table of statistically significant differences in spiral ganglion neuron density in the apical, mid, and basal turns. An ANOVA was performed using either Tukey HSD or Tamhane post hoc analysis (see "[Materials and methods](#Sec2){ref-type="sec"}")

Overall, there appeared to be an apex-to-base gradient of severity of effects on SG neuron density in the mutant genotypes at 8 weeks of age. Density was shown to be significantly lower in both the basal and mid turns compared to apical turns in the *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ and *Casp3*^*mldy*^*/Casp3*^*tm1Flv*^ mice (*P* \< 0.05); however, no differences were seen between the basal and mid turns. The same trend was seen in *Casp3*^*mldy*^*/Casp3*^*mldy*^, although there were no significant differences. We also analysed SG neuron density at an earlier time point, P18, and found that at this age there were no significant reductions in any of the genotypes (data not shown). Moreover, given our observations on the apex-to-base gradient of SG neuron density, we analysed the expression of Caspase 3 across the cochlea turn in wild-type, *Casp3*^*mldy*^*/+* , and *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice. We did not observe any apex-to-base gradient in Caspase-3 expression that might underlie the relative preservation of spiral ganglion cells in the apical regions (data not shown). We also analysed the expression of Caspase 7 for differences in expression across the cochlear turn that might contribute to the loss of SG neurons in the base, but again we did not observe any apex-to-base gradient (data not shown).

Discussion {#Sec23}
==========

We have identified a new mutation, *melody*, from an ENU recessive deafness screen, demonstrating a profound hearing loss. *Melody* carries a nonconservative mutation at the catalytic cysteine (amino acid 163) of Caspase 3. Caspase 3 is responsible either totally or in part for the cleavage of a large number of cytoskeletal proteins such as gelsolin, actin, and α-fodrin, proteins involved with cell cycle and proliferation such as Rb and p27^kip1^, and activating protein kinases such as MEKK1 (reviewed in Earnshaw et al. [@CR6]). In a number of cases, Caspase 7, another executioner caspase that shares a high level of homology with Caspase 3, may take over the cleavage of substrates in its absence. For some substrates such as α-fodrin, which is heavily involved with plasma membrane blebbing, Caspase 3 is indispensible for apoptotic cleavage (Janicke et al. [@CR12]), although for neuronal apoptosis to occur it must be cleaved by both calpain and Caspase 3 at different sites (Nath et al. [@CR18]). Calpain has long been associated with neuronal necrosis, and, interestingly, Caspase 3 has been shown to be involved with the cleavage of calpastatin, which in turn leads to reduced inhibition of calpain. Conversely, pro-Caspase 3 is a substrate of calpain, but instead of processing it into the active subunits, cleavage results in a truncation that reduces the chance of activation by initiator caspases (Wang [@CR23]). It would be expected that the lack of a catalytically active Caspase 3 in *melody* or null homozygote mice leads to these pathways being compromised, resulting in a lack of the necessary developmental apoptosis in certain cell types in the organ of Corti and the brain. Most noteworthy for this study, Morishita et al. ([@CR17]) showed that Caspase 3 is expressed in spiral ganglion neurons during inner-ear development where it presumably plays some role in apoptosis.

The ENU *melody* mutation causes a similar phenotype to *Casp3* -ull mice. However, there are some differences in severity. These differences may be due to the genetic background of the mice. *Casp3*^*tm1Flv*^-null mice were originally created on a 129/sv genetic background and displayed severe brain hyperplasia and consequently died *in utero* or very shortly after birth (Kuida et al. [@CR15]). The null mice used in this study were created by outcrossing heterozygous 129/sv null to C57BL/6 J for ten generations before intercrossing to produce the B6.129S1-*Casp3*^*tm1Flv*^/J mouse line. These mice were reported to have a much less severe phenotype than the 129/sv null; they displayed only minor brain abnormalities but developed sensorineural hearing loss due to degeneration of sensory cells (Takahashi et al. [@CR21]). Mice homozygote for a different null allele, *Casp3*^*tm1Kin*^, which were created and maintained on a C57BL/6 J background, also developed deafness due to degeneration of sensory hair cells and spiral ganglion (Morishita et al. [@CR17]). Abnormally low ratios of homozygote null mice were not reported in these studies. However, we maintained our null mice by outcrossing to C3H and intercrossing progeny to produce *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ animals. The number of *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ animals surviving (18 of 159, 11.4%) was significantly lower than the 25% expected according to Mendelian inheritance from a recessive mating scheme (χ^2^*P* = 0.00007). As already shown, the percentage of *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice, also maintained on C3H, was very similar (11.3%), and we demonstrated for *melody* that 50% of 17.5-dpc homozygous embryos displayed severe blebbing of the head, potentially contributing to prenatal losses. It would appear that both mutations display embryonic lethality on a C3H background.

The lack of an ABR response reflecting a profound hearing loss in *Casp3*^*mldy*^*/Casp3*^*mldy*^ mice was already apparent by 2 weeks of age. It was previously reported that 2-week-old *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ mice showed an atypical ABR response to a 70-dB-SPL stimulus but showed no response to a 100-dB-SPL stimulus by five weeks (Takahashi et al. [@CR21]). It is also documented that some of the *Casp3*^*tm1Kin*^/*Casp3*^*tm1Kin*^ mice showed very elevated but not absent ABR responses at four months of age (Morishita et al. [@CR17]). Both *Casp3* knockouts were analysed on a C57BL/6 background, a strain that shows age-related hearing loss. Overall, the *melody* homozygotes exhibited a hearing loss as profound as the knockout mutations, particularly when taking into account that *melody* was analysed on a C3H hearing-sensitive background.

Degeneration and fusion of OHCs was reported in the previous study of the *Casp3*^*tm1Flv*^ mutant (Takahashi et al. [@CR21]). Moreover, Takahashi et al. reported some fusion of IHC stereocilia, although this was not particularly extensive and the bulk of IHC stereocilia appeared normal. Interestingly, the fusion of IHC that we observed in the *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^ mice appears much more extensive, affecting the bulk of inner-ear stereocilia. Takahashi et al. ([@CR21]) also reported increased numbers of border cells and persistence of the greater epithelial ridge, from which border cells and inner hair cells develop in the organ of Corti.

In the *melody* mutation we focused on its effects on degeneration of spiral ganglion neurons and carried out a detailed analysis of neuronal density in all genotypes across the cochlear turns. Morishita et al. ([@CR17]) reported degeneration of the spiral ganglion in the Caspase-3 knockout beginning at 30 days but did not quantify the effect or investigate its distribution across the cochlear turns. We have demonstrated that both homozygous mutants and the compound mutant show extensive hypocellularity of spiral ganglion neurons in Rosenthal's canal at eight weeks of age. We made two important observations. First, there is evidence of a gradient of severity in *Casp3*^*mldy*^*/Casp3*^*mldy*^, *Casp3*^*tm1Flv*^/*Casp3*^*tm1Flv*^, and the compound mutant, with the apical turns being severely affected the least. As a consequence of this observation, for both Caspase 3 and Caspase 7 we examined whether there was any evidence of apex-to-base gradients of expression in the cochlea but found none. Second, we noted that *melody* heterozygotes appeared to show some evidence of reductions in neuronal density in the spiral ganglion. Although they did not display the extent of hypocellularity that was seen in the *melody* homozygotes, null homozygotes, or compound mutants, the population of spiral ganglion neurons was significantly lower in apical and mid turns compared to that in heterozygous knockout mice (*Casp3*^*tm1Flv*^/+). Interestingly, there is also some evidence to suggest that effect on neuronal density is more severe in the compound mutant (*Casp3*^*mldy*^*/Casp3*^*tm1Flv*^) compared to that in the homozygous knockout, which would be consistent with the *melody* mutation exerting a dominant negative effect. Overall, our evidence indicates that the *melody* mutation may show some dominant effects in the spiral ganglion, although we have seen no dominant effects from ABR measurements where auditory thresholds correspond to wild type in the heterozygote. It is notable that we found some reduction in protein levels in the *melody* heterozygote (see "[Results](#Sec13){ref-type="sec"}"), though this was not significant. The reduced SG neuron density in *melody* heterozygotes is also noteworthy given that heterozygotes show no hair cell abnormalities or loss. The absence of any degeneration of SG neurons at P18 for any genotype might suggest that SG neuron loss is secondary to hair cell loss. However, our observations in *melody* heterozygotes would indicate that the Caspase-3 mutant acts directly on the spiral ganglion cells and not as a secondary consequence of hair cell loss.

It is not inconceivable, given the nature of the *melody* mutation, that mutant protein may bind, but not degrade, and thus sequester substrates leading to dominant effects in the heterozygote in some tissues. Indeed, the exact substitution caused by the *melody* mutation has been created by targeted mutagenesis and is often used as a catalytically inactive form of Caspase 3 for the study of caspase activity in *in vitro* experiments (Bose and Clark [@CR1]; Feeney and Clark [@CR7]; Gu et al. [@CR8]; Kang et al. [@CR14]; Van Criekinge et al. [@CR22]). This catalytically inactive form has been shown to fold into the active form and bind to substrates of Caspase 3 but it is unable to cleave them due to the mutated active site (Dejosez et al. [@CR5]).

In conclusion, we have identified a new Caspase-3 mutation, leading to the alteration of the catalytically active cysteine, and explored its effect on auditory function and the spiral ganglion in the inner ear. We have demonstrated a gradient of effect in the spiral ganglion across the cochlea turns and provided evidence that *melody* may exert dominant effects, at least in the spiral ganglion. The development of an in vivo model of the cysteine 163 mutation should enhance our understanding of the action of Caspase 3. In particular, given the potential for this mutant to bind and sequester proteins, it will be interesting to undertake a more comprehensive phenotype analysis of this mutant across a range of tissues in both heterozygote and homozygote mice; these experiments are underway.
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